BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -13.18% | -33.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.18% | -33.87% | |||
| Cost of Revenue | -20.39% | -40.12% | |||
| Gross Profit | -9.96% | -30.64% | |||
| SG&A Expenses | -29.77% | -27.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.70% | -30.27% | |||
| Operating Income | 17.84% | 29.01% | |||
| Income Before Tax | 11.83% | 49.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.83% | 49.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.83% | 49.59% | |||
| EBIT | 17.84% | 29.01% | |||
| EBITDA | 18.24% | 29.05% | |||
| EPS Basic | 68.24% | -13.64% | |||
| Normalized Basic EPS | 22.37% | 55.75% | |||
| EPS Diluted | 68.24% | -13.64% | |||
| Normalized Diluted EPS | 22.37% | 55.75% | |||
| Average Basic Shares Outstanding | 14.20% | 13.92% | |||
| Average Diluted Shares Outstanding | 14.20% | 13.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
